Delivery Order SPE2DP20D0002-SPE2DP24F7166
Award Date
8/22/24
Potential Completion Date
8/27/24
Potential Value
$159K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. has a history of providing critical drug products, such as vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 fixed-price delivery order is for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $64,352,514.80 IDC with the Department of Veterans...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has a final completion date of September 24, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various...
This federal contract award, valued at $5,285,021.76, was issued by the Defense Logistics Agency (DLA) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a firm-fixed-price delivery order for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. The award has an ultimate completion date of February 4, 2025. Teva Pharmaceuticals USA, Inc. is a major supplier of critical pharmaceutical products to various...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The firm-fixed-price delivery order has a ceiling value of $476,414.19 and a completion date of April 30, 2024. The contract is not set aside for a specific business designation. Teva Pharmaceuticals USA, Inc. is a leading global pharmaceutical company that...
The federal contract award, with ID SPE2DP20D0002|SPE2DP24F6264, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $476,414.19, is for the delivery of Adenovirus Type 4 vaccine, a critical product supporting military immunization programs. This is a delivery order contract with a firm-fixed price pricing type, and the ultimate completion date is July 30,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm-fixed price of $317,609.46 and a completion date of July 30, 2024. Teva Pharmaceuticals USA, Inc. is a significant supplier of critical pharmaceutical products to various U.S. federal government agencies, including the Department of Veterans...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...